Prostate Cancer

October 21, 2020

The intervention led to a significant reduction in urologists' opioid prescribing after prostatectomy and nephrectomy.

October 21, 2020

Transperineal targeted biopsy with electromagnetic-tracking fusion technology is low risk and detects clinically significant prostate cancer as well as the transrectal fusion-guided approach, investigators report.

October 20, 2020

Adding the PLK1 inhibitor to abiraterone acetate and prednisone led to disease control in patients showing initial signs of progression on abiraterone.

October 19, 2020

Although the overall incidence of prostate cancer has declined, the percentage of patients with metastatic disease at diagnosis has increased over the last decade.

October 16, 2020

The technique also led to better preservation of anatomical structures around the urethra and achieved a low rate of positive surgical margins.

October 15, 2020

When adjusting for only age and year of diagnosis, the mortality rate was 51% higher for Black versus White patients receiving the procedure; however, when the model adjusted for all clinical and nonclinical factors, this survival disparity dropped to 20%.

October 14, 2020

The immunotherapy was also associated with fewer emergency department visits than either of the androgen pathway receptor inhibitors.

October 08, 2020

Cognitive screening is recommended in patients receiving androgen-deprivation therapy.

October 05, 2020

Rucaparib pharmacokinetics in men with prostate cancer were comparable to those reported for women with ovarian cancer.

September 30, 2020

The ad hoc analysis also examined PSA response in the pivotal phase 3 ARAMIS trial.